These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo Schey R; Alla SP; Midani D; Parkman HP Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of esophagogastroduodenoscopy in changing treatment outcome in refractory gastro-esophageal reflux disease. Kwak YE; Saleh A; Abdelwahed A; Sanchez M; Masoud A Scand J Gastroenterol; 2022 Jan; 57(1):124-130. PubMed ID: 34669534 [TBL] [Abstract][Full Text] [Related]
7. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. Bonavina L; Saino G; Bona D; Sironi A; Lazzari V J Am Coll Surg; 2013 Oct; 217(4):577-85. PubMed ID: 23856355 [TBL] [Abstract][Full Text] [Related]
8. Paradigm shift in the management of gastroesophageal reflux disease. Richards WO; Houston HL; Torquati A; Khaitan L; Holzman MD; Sharp KW Ann Surg; 2003 May; 237(5):638-47; discussion 648-9. PubMed ID: 12724630 [TBL] [Abstract][Full Text] [Related]
9. Gastroesophageal reflux: management guidance for the pediatrician. Lightdale JR; Gremse DA; Pediatrics; 2013 May; 131(5):e1684-95. PubMed ID: 23629618 [TBL] [Abstract][Full Text] [Related]
10. Endoscopic Advances in the Diagnosis and Management of Gastroesophageal Reflux Disease. Loganathan P; Gajendran M; Perisetti A; Goyal H; Mann R; Wright R; Saligram S; Thosani N; Umapathy C Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064549 [TBL] [Abstract][Full Text] [Related]
11. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease. Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oksenberg D; Perez-Castilla A; Netto MG; Soffer E; Crowell MD Endoscopy; 2013 Aug; 45(8):595-604. PubMed ID: 23881803 [TBL] [Abstract][Full Text] [Related]
13. Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux. Ganz RA; Edmundowicz SA; Taiganides PA; Lipham JC; Smith CD; DeVault KR; Horgan S; Jacobsen G; Luketich JD; Smith CC; Schlack-Haerer SC; Kothari SN; Dunst CM; Watson TJ; Peters J; Oelschlager BK; Perry KA; Melvin S; Bemelman WA; Smout AJ; Dunn D Clin Gastroenterol Hepatol; 2016 May; 14(5):671-7. PubMed ID: 26044316 [TBL] [Abstract][Full Text] [Related]
14. Updates on Surgical Treatment for Gastroesophageal Reflux Disease. Kendrick K; Kothari SN Am Surg; 2023 Jun; 89(6):2730-2737. PubMed ID: 36789472 [TBL] [Abstract][Full Text] [Related]
15. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease. Watson TJ; Peters JH Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis. Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934 [TBL] [Abstract][Full Text] [Related]
17. LINX Skubleny D; Switzer NJ; Dang J; Gill RS; Shi X; de Gara C; Birch DW; Wong C; Hutter MM; Karmali S Surg Endosc; 2017 Aug; 31(8):3078-3084. PubMed ID: 27981382 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Hunter JG; Kahrilas PJ; Bell RC; Wilson EB; Trad KS; Dolan JP; Perry KA; Oelschlager BK; Soper NJ; Snyder BE; Burch MA; Melvin WS; Reavis KM; Turgeon DG; Hungness ES; Diggs BS Gastroenterology; 2015 Feb; 148(2):324-333.e5. PubMed ID: 25448925 [TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux disease. Are we acting in the best interest of our patients? Tebala GD Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4553-4556. PubMed ID: 27874941 [TBL] [Abstract][Full Text] [Related]